Close Menu

Going Generic

Pfizer is looking to expand its role in the generics market, reports the Health Blog at the Wall Street Journal. To grow in this market, the president of Pfizer's established products business says they will "develop its own new products, buy licenses or acquire companies." Simmons did not say whether Pfizer was looking into acquiring the Icelandic Actavis Group or the German Ratiopharm, which are both on the market.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.